Lishui Central Hospital
In research, Lishui Central Hospital stands highest in Medicine (#3,121 of 10,443 worldwide), Health Sciences (#3,902 of 11,982 worldwide) and Life Sciences (#3,340 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 6.4× its share of world research.
- World rank, 2022–2025
- #6,389 of 28,054 · #14,088 all time
- Rank in China
- #1,335 of 3,058
- Research works
- 1.2k ▲ 3% vs 2013–17
- Citations
- 7.7k 6.4 per fractional work
- Top-10% rate
- 17.3% record average 16.5%
- Open access
- 45% world 28%
What is Lishui Central Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,121 of 10,443 | 14.7% | 244 | #6447 | |
| Health SciencesDomain | #3,902 of 11,982 | 14.9% | 255 | #8107 | |
| Life SciencesDomain | #3,340 of 7,800 | 20.3% | 87 | #7071 |
Each strip is that field’s whole ranked pool, with the notch where Lishui Central Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#6,447 #3,121
- Health Sciences#8,107 #3,902
- Life Sciences#7,071 #3,340
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Lishui Central Hospital specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 6.4× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 36.8 works6.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.4×. Every wedge is a field page.
- Immunology and Microbiology 3.4×
- Medicine 3.4×
- Biochemistry, Genetics and Molecular Biology 3.0×
- Nursing 1.9×
- Neuroscience 1.6×
- Dentistry 1.3×
- Pharmacology, Toxicology and Pharmaceutics 1.2×
- Veterinary 0.7×
- Health Professions 0.5×
- Psychology 0.4×
- Materials Science 0.4×
- Agricultural and Biological Sciences 0.2×
- Chemistry 0.2×
- Engineering 0.2×
- Mathematics 0.1×
- Energy 0.1×
- Computer Science 0.1×
- Earth and Planetary Sciences 0.1×
- Environmental Science 0.1×
- Physics and Astronomy 0.1×
- Economics, Econometrics and Finance 0.1×
- Chemical Engineering 0.1×
- Social Sciences 0.1×
- Decision Sciences 0.1×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Lishui Central Hospital?
Ranked on the composite score, Jiansong Ji, Jiansong Ji and Jianfei Tu lead among researchers whose main affiliation is Lishui Central Hospital.
- 1 Jiansong Ji China · #362,671 worldwide 101 citations · 44 works
- 2 Jiansong Ji China · #688,241 worldwide 53 citations · 17 works
- 3 Jianfei Tu China · #1,475,174 worldwide 26 citations · 17 works
Which keywords describe research at Lishui Central Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cancer, Epidemiology, Diagnosis, Management, Tumor Microenvironment, Chemotherapy and Oxidative Stress.
- Adjuvant Therapy
- Rituximab
- Ferroptosis
- Cancer Progression
- Neuroinflammation
- Metabolism
- Guidelines
- Insulin Resistance
- Immunity
- Chronic Kidney Disease
- Immune Response
- Metastasis
- Metabolic Syndrome
- Clinical Practice Guidelines
- Gene Expression
- Tumor Microenvironment
- Chemotherapy
- Management
- Oxidative Stress
- Inflammation
- Epidemiology
- Cancer
- Diagnosis
- Cardiovascular Disease
- Treatment
- Quality of Life
- Immunotherapy
- Biomarkers
- Risk Factors
- Prognostic Factors
- Cell Death
- Cancer Therapy
- Neuroprotection
- Global Burden
- Radiotherapy
- Prognosis
- Tumor Targeting
- Lipid Peroxidation
- GPX4
- Sepsis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology36▲ 2.5×88 topics
- Inflammation36▲ 4.7×68 topics
- Cancer28▲ 5.5×43 topics
- Oxidative Stress20▲ 3.2×41 topics
- Diagnosis18▲ 5.3×29 topics
- Management17▲ 5.8×24 topics
- Cardiovascular Disease16▲ 3.9×30 topics
- Chemotherapy16▲ 6.1×21 topics
- Treatment16▲ 3.5×31 topics
- Tumor Microenvironment14▲ 8.7×8 topics
- Quality of Life13▲ 2.4×29 topics
- Gene Expression12▲ 5.4×12 topics
- Immunotherapy12▲ 4.6×16 topics
- Clinical Practice Guidelines12▲ 5.9×13 topics
- Biomarkers11▲ 4.3×12 topics
- Metabolic Syndrome11▲ 3.6×19 topics
- Risk Factors10▲ 2.5×20 topics
- Metastasis10▲ 7.7×12 topics
- Prognostic Factors10▲ 6.0×14 topics
- Immune Response10▲ 4.5×16 topics
- Cell Death9▲ 10×5 topics
- Chronic Kidney Disease9▲ 9.9×8 topics
- Cancer Therapy8▲ 3.9×19 topics
- Immunity8▲ 5.2×9 topics
- Neuroprotection8▲ 5.9×14 topics
- Insulin Resistance7▲ 4.3×9 topics
- Global Burden7▲ 3.6×10 topics
- Guidelines7▲ 4.0×13 topics
- Radiotherapy7▲ 4.9×9 topics
- Metabolism7▲ 3.6×24 topics
- Prognosis6▲ 5.2×9 topics
- Neuroinflammation6▲ 5.7×6 topics
- Tumor Targeting6▲ 8.6×3 topics
- Cancer Progression6▲ 8.1×6 topics
- Lipid Peroxidation5▲ 14×2 topics
- Ferroptosis5▲ 18×1 topic
- GPX45▲ 18×1 topic
- Rituximab5▲ 9.3×4 topics
- Sepsis5▲ 8.1×6 topics
- Adjuvant Therapy5▲ 10×2 topics
Which research topics does Lishui Central Hospital publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Tuberculosis Research and Epidemiology, Lymphoma Diagnosis and Treatment and Nanoplatforms for cancer theranostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 5 works
- 2 Tuberculosis Research and Epidemiology Infectious Diseases 3 works
- 3 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 4 Nanoplatforms for cancer theranostics Biomedical Engineering 3 works
- 5 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
- 6 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 3 works
- 7 Diagnosis and treatment of tuberculosis Surgery 3 works
- 8 Acute Ischemic Stroke Management Epidemiology 3 works
- 9 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 3 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Lishui Central Hospital's research output changed?
Output in 2018–2022 was 3% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lishui
- Lishui University
- Lishui City People's Hospital
- Lishui Vocational and Technical College
- Lishui Academy of Agricultural Sciences
- Lishui Academy of Forestry
- Lishui Maternity and Child Health Care Hospital
- Nanjing Lishui Electronics Research Institute (China)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.